Xu Wei, Ge Penglei, Liao Wenjun, Ren Jinjun, Yang Huayu, Xu Haifeng, Sang Xinting, Lu Xin, Zhong Shouxian, Mao Yilei
Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Asia Pac J Clin Oncol. 2017 Oct;13(5):e312-e320. doi: 10.1111/ajco.12494. Epub 2016 Apr 21.
Primary clear cell carcinoma of liver (PCCCL) is a specific and rare subtype of primary hepatocellular carcinoma (HCC). We performed a retrospective study with long-term follow-up to investigate predictive factors and prognosis of intrahepatic recurrences of PCCCL after radical resection.
We retrospectively analyzed records of 38 patients with PCCCL who were diagnosed at Peking Union Medical College Hospital between January 1989 and September 2010, with a long-term follow up to January 2015, to determine their clinical characteristics and postoperative survival. The data were compared with 400 patients received radical hepatectomy for common type hepatocellular carcinoma (CHCC) during the study period.
PCCCL tumors were smaller than those of CHCC (P < 0.001) and the incidence of vascular invasion of tumors in PCCCL group was significantly lower than that in CHCC (P = 0.029). The 1-, 3-, and 5-year overall survival (OS) for PCCCL patients were 94.6%, 67.3%, and 58.5%, respectively; 1-, 3-, and 5-year disease-free survival (DFS) were 89.2%, 54.1%, and 48.6%, respectively. Both OS and DFS were significantly better for PCCCL patients than for CHCC (P = 0.039 and 0.044). Cox modeling showed high Edmondson grade to be the only independent predictive factor for survival of PCCCL patients, which were different from those of CHCC.
PCCCL is a less malignant subtype of HCC than CHCC, patients with PCCCL likely have later intrahepatic recurrences and a better prognosis. Edmondson grade predicts survival of patients with PCCCL after curative resection; those with higher Edmondson grades may require more careful follow-up and aggressive post-hepatectomy therapy.
肝原发性透明细胞癌(PCCCL)是原发性肝细胞癌(HCC)一种特殊且罕见的亚型。我们进行了一项长期随访的回顾性研究,以探讨PCCCL根治性切除术后肝内复发的预测因素及预后。
我们回顾性分析了1989年1月至2010年9月在北京协和医院确诊的38例PCCCL患者的记录,并对其进行长期随访至2015年1月,以确定他们的临床特征和术后生存情况。将这些数据与研究期间接受根治性肝切除术的400例普通型肝细胞癌(CHCC)患者的数据进行比较。
PCCCL肿瘤比CHCC肿瘤小(P < 0.001),PCCCL组肿瘤血管侵犯发生率显著低于CHCC组(P = 0.029)。PCCCL患者1年、3年和5年总生存率(OS)分别为94.6%、67.3%和58.5%;1年、3年和5年无病生存率(DFS)分别为89.2%、54.1%和48.6%。PCCCL患者的OS和DFS均显著优于CHCC患者(P = 0.039和0.044)。Cox模型显示高Edmondson分级是PCCCL患者生存的唯一独立预测因素,这与CHCC不同。
与CHCC相比,PCCCL是HCC中恶性程度较低的亚型,PCCCL患者肝内复发可能较晚,预后较好。Edmondson分级可预测PCCCL患者根治性切除术后的生存情况;Edmondson分级较高的患者可能需要更密切的随访和积极的肝切除术后治疗。